DigestRedComo funciona
Red
/
Empresas
MO
No verificado

MOMA Therapeutics

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

6 Comunicados de prensa

Ver todos los comunicados de prensa
17/07/2025
Salud
Sanidad
Medicina - Varios
Farmacéutica
Biotecnología
Industria
MOMA Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial for MOMA-341, a Highly Potent and Selective Werner Helicase Inhibitor
Fuente
MOMA Therapeutics
Editor
Business Wire
1.00
0
17/04/2025
Eventos
Ciencia
Biotecnología
Medicina - Varios
Salud
Farmacéutica
Oncología
MOMA Therapeutics to Present Multiple Posters at the American Association for Cancer Research Annual Meeting 2025
Fuente
MOMA Therapeutics
Editor
Business Wire
1.00
0
01/04/2025
MOMA Therapeutics Appoints Susan Pandya, M.D., to Board of Directors and Expands Management Team
Fuente
MOMA Therapeutics
Editor
Business Wire
1.00
0
08/01/2025
Mercado laboral
Industria
Ciencia
Higiene alimentaria
Biotecnología
Medicina - Varios
Salud
Farmacéutica
MOMA Therapeutics Provides Corporate Update and Announces Exclusive License Agreement for Selective PARP1 Inhibitor
Fuente
MOMA Therapeutics
Editor
Business Wire
1.00
0
19/08/2024
Ciencia
Medicina - Varios
Biotecnología
Sanidad
Salud
Farmacéutica
Oncología
Industria
MOMA Therapeutics Announces Initiation of Phase 1 Clinical Trial for MOMA-313, a Novel Polymerase Theta Helicase Inhibitor
Fuente
MOMA Therapeutics
Editor
Business Wire
1.00
0
25/06/2024
MOMA Therapeutics Appoints Marc Ballas, M.D., as Head of Clinical Development, and Adam Thomas as Chief People & Experience Officer
Fuente
MOMA Therapeutics
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0